BIO International
We are proud to have our Head of WuXi Biology, Dr. Letian Kuai, and our Head of WuXi Chemistry, Dr. Tao Guo, provide thought leadership via two presentations in the Bio Process International (BPI) Theater. Topics will include machine learning, targeted protein degradation, covalent protein inhibition, RNAi, and gene therapy.
WuXi AppTec offers expertise in all major disease areas and target classes, across all therapeutic modalities. From antibodies, oligonucleotides, and peptides to tumor models, biomarkers, and cell therapies, our state-of-the-art services support projects from target discovery to candidate selection and beyond.
To pre-arrange a dedicated one-on-one meeting, fill out the form on the right or contact our VP of Business Development, Declan Ryan, on the BIO One-on-One Partnering Platform
WuXi AppTec Presentations in the Bio Process International (BPI) Theater:
| Date | Speaker | Title |
| Wednesday, June 7th, 11:00 AM | Dr. Letian Kuai, VP and Head of WuXi Biology | Advancing Data-Driven Drug Discovery through Machine Learning and Computer-Aided Design |
| Wednesday, June 7th, 2:05 PM | Dr. Tao Guo, SVP and Head of WuXi Chemistry | Enabling and Accelerating Innovative and Emerging Modalities in Drug Discovery |
- Discovery Services
- WuXi Biology Overview
- Targeted Protein Degradation
- In Vitro Neuroscience Services
- Oligonucleotide Biology Platform
- One-Stop Target-to-Hit Platform
- DNA-Encoded Libraries
- Antibody and Protein Services
- Patient-Derived Xenograft (PDX) Tumor Models
- Cell Line-Derived Xenograft (CDX) Tumor Models
- Oncology and Immuno-Oncology Services
- Virology and Viral Vector Platforms
